Login

Switch On Your HIV Smarts.

CROI 2015: Tenofovir Alafenamide and a New Maturation Inhibitor

CROI 2015: Tenofovir Alafenamide and a New Maturation Inhibitor

March 2, 2015, by

What’s new in the world of HIV drug development? CROI brought us updates on a potentially safer version of tenofovir and a new type of drug that just established proof-of-concept. Read More

CROI 2015: “On-Demand” PrEP Shows High Efficacy in IPERGAY Trial

CROI 2015: “On-Demand” PrEP Shows High Efficacy in IPERGAY Trial

February 25, 2015, by

Exciting results from the IPERGAY study—on the effectiveness of intermittent PrEP—were recently announced. Read More

CROI 2015: Partners PrEP Demo project: Near Elimination of HIV Transmission with ART and PrEP

CROI 2015: Partners PrEP Demo project: Near Elimination of HIV Transmission with ART and PrEP

February 25, 2015, by

New data from CROI show that that PrEP is effective as a temporary “bridge” in serodiscordant couples until viral suppression is achieved. Read More

CROI 2015: PROUD Study of “Real World” PrEP Reports 86% Efficacy

CROI 2015: PROUD Study of “Real World” PrEP Reports 86% Efficacy

February 24, 2015, by

Exciting results from the PROUD study show that PrEP can offer excellent protection against HIV when delivered to men who have sex with men outside of clinical trials. Read More

CROI 2015: Neutralizing Antibodies Provide Hope for an HIV Vaccine

CROI 2015: Neutralizing Antibodies Provide Hope for an HIV Vaccine

February 24, 2015, by

A vaccine for HIV has thus far proven to be elusive. Galit Alter shared insight on where research in the field is headed. Read More